Eric Kelsic

CEO & Co-Founder at Dyno Therapeutics

Prior to founding Dyno, Eric led a team to develop the technology underlying Dyno's Al-powered protein engineering platform in George Church's lab at the Wyss Institute of Harvard Medical School. There he measured the first comprehensive fitness landscape of the adeno- associated virus (AAV) capsid protein and co-discovered the AAV MAAP gene. He holds a PhD in Systems Biology from Harvard University and a BS in Physics from Caltech. During his PhD he studied high-order interactions among soil microbes and developed MAGE-Seq, a method combining multiplexed genome-engineering with massively parallel phenotyping. As an undergrad he led one of the first studies of community structure on Facebook networks. He enjoys soccer, hiking, minimal techno and solving puzzles.

Location

Cambridge, United States

Links

Previous companies


Org chart


Teams


Offices


Dyno Therapeutics

4 followers

Dyno Therapeutics is a Cambridge based, VC-backed biotech startup that uses next-gen DNA technologies and machine learning to engineer Adeno-associated Virus (AAV) capsids for effective delivery of gene therapies.


Employees

51-200

Links